Objectives: Staphylococcus epidermidis is often associated with biofilm infections related to medical implants. The aim of the present study was to find furanones that decrease biofilm formation without irritative or genotoxic effects, or effects on S. epidermidis growth.
Introduction
The coagulase-negative staphylococci (CoNS) are commensal bacteria on human skin and mucous membranes. Staphylococcus epidermidis was long considered harmless, but is now the most frequent CoNS isolate, 1 as well as a major nosocomial pathogen often found in catheter-and implant-associated infections. 2, 3 The virulence is primarily related to the ability of S. epidermidis to form biofilms on the surfaces of medical devices. Currently, there are few effective means to prevent medical device-related infections. 4 Biofilm infections are difficult to treat due to increased resistance to both antibiotics and the human immune system. 5 -7 Antimicrobial coating of implants is the most frequently used method to prevent S. epidermidis infections. This may cause antibiotic resistance development and lead to even greater difficulties in treating catheter-and implant-related infections with subsequent costs for the health system.
By producing brominated furanones, the red algae Delisea pulchra inhibits microbial colonization on its surface. 8 The natural furanones may control multicellular behaviour induced by autoinducer-1 (AI-1)
9 -11 and autoinducer-2 (AI-2) 12,13 in Gram-negative microorganisms. AI-1 and AI-2 signals are used for cell-to-cell communication to control the production and secretion of virulence factors, proteolytic activities, carbohydrate metabolism and biofilm formation in various microbial species. 14 -18 Natural furanones also inhibit growth in the Gram-positive Bacillus subtilis. 19, 20 Synthetic furanones similar to those found in D. pulchra are also shown to interfere with microbial communication induced by AI-1 11 and AI-2.
21
S. epidermidis carries the luxS gene encoding the AI-2 synthase.
The synthetic (Z)-4-bromo-5-(bromomethylene)furan-2(5H)-one and (Z)-5-(bromomethylene)furan-2(5H)-one appear to inhibit AI-1-mediated microbial communication and decrease the severity of Pseudomonas aeruginosa lung infection in mice. 22 We recently published a novel and simple method for synthesis of (Z)-5-(bromomethylene)furan-2(5H)-one (F202, Figure 1) . 23 This furanone decreased biofilm formation by Streptococcus anginosus, Streptococcus intermedius and Streptococcus mutans without affecting their growth, presumably through interference with the AI-2 signalling pathway. 21 Despite promising inhibitory effects of furanone on microbial biofilm formation, 12,19,21,24 -26 reports on the effects of furanone on eukaryotic cell viability and toxicity are scarce 24,26 -28 and reports on genotoxic effects seem to be lacking.
The aim of the present study was to find furanones that effectively decrease biofilm formation at concentrations without antimicrobial, irritative or genotoxic effects. From the screening for potential inhibitory effects on AI-2 communication, four synthetic furanones were tested in a S. epidermidis biofilm assay. From the biofilm assay, two furanones were chosen for further studies. First, the antibacterial effects of the two furanones were elucidated by measuring total growth and investigating the MICs. Second, it was determined whether the effects of the two furanones could be eliminated by (S)-4,5-dihydroxy-2, 3-pentanedione (DPD), the precursor of AI-2. Thereafter, the two furanones were investigated for an irritative effect by the Hen's egg test chorioallantoic membrane (HET-CAM) procedure 29, 30 and toxic reactions in mice using a membrane array comprising 263 genes associated with toxic responses. This was followed by a study of the effect of the furanones on global gene expression using microarrays representing 30 000 genes found in the mouse genome.
Methods

Furanones
The furanones ( Figure 1 ) were synthesized as described previously, 23,31 except for F101 and F201 (T. Benneche and Z. Hussain, unpublished data). The furanones were dissolved and diluted in absolute ethanol to a final stock concentration of 60 mM and stored at 2208C.
Bacterial strains and culture conditions
The bacterial strains used in this study are listed in Table 1 . Vibrio harveyi BB170 was grown as described previously. 32, 33 Incubation was with shaking, at 200 rpm, in a Minitron Incubator Shaker (Infors AG, Bottmingen, Switzerland) at 308C. The S. epidermidis cells were grown on brain heart infusion (BHI) agar plates (Difco Laboratories, Detroit, MI, USA) for 24 h at 378C in an aerobic atmosphere before inoculation into BHI medium (Difco Laboratories) for biofilm formation and growth. 
Bioluminescence assay
AI-2 communication was assessed as the ability of cell-free culture supernatants to induce bioluminescence in V. harveyi BB170. Cellfree S. epidermidis supernatants were prepared by centrifugation of second overnight culture (8000 g for 10 min) followed by filtration through 0.2 mm filters (Schleicher & Schuell, Germany). The bioluminescence assay was performed essentially as described previously, 32, 33 with slight modifications. 34 Biofilm assay S. epidermidis was allowed to form biofilm on furanone-coated polystyrene discs (Nunc, Roskilde, Denmark). For coating of the discs, the furanones were diluted to 60 mM in ethanol. One millilitre of 60 mM furanone was added to wells of a polystyrene microtitre plate (Nunc), each containing a disc. The solvent was allowed to evaporate for 24 h at room temperature. This concentration of furanone had been shown to be effective against streptococcal biofilm formation without an antimicrobial effect. 21 A plain ethanol coating was included as a negative control in the biofilm assay. The ethanol coating had no antimicrobial effect (data not shown). Second overnight cultures of S. epidermidis were diluted 1:100 in BHI. Samples of 1 mL were transferred to the wells. Biofilm was allowed to form on the discs for 18 h at 378C incubation in an aerobic atmosphere. Biofilm mass was quantified after removing the discs from the wells. Unattached cells were removed by rinsing the discs twice in distilled water. The discs were then immersed into new wells, and the biofilms were stained for 10 min with a 0.1% solution of safranin. The discs were again transferred to new wells after rinsing with distilled water. Bound dye was released from stained biofilm using 30% glacial acetic acid, and optical density (OD) at 530 nm was measured in a Synergy HT Multi-Detection Microplate Reader (Biotek, VT, USA).
To assess possible interference of the furanones with S. epidermidis communication, DPD (OMM Scientific Inc., TX, USA) was added to the growth medium at various concentrations. Biofilm mass was allowed to form on furanone-coated surfaces and quantified as described above.
Antimicrobial effect
A possible antimicrobial effect of the furanones was assessed by determining the MIC as described previously, 35 with modifications. A 96-well sterile microtitre plate (Costar, Flat bottom, Ultra low attachment, Corning Incorporated, Corning, NY, USA) was used in the assay. The furanones were serially diluted in steps of 0.625 within the range 4096-6 mM. Final volume in the wells was 150 mL and final dilution of the bacteria 1:2000. The plates were incubated at 378C in an aerobic atmosphere for 18 h and OD 600 was measured.
Measuring total growth, including both planktonic and biofilm cells scraped together in the wells, assessed a possible antimicrobial effect of the furanones on S. epidermidis. Biofilm was allowed to form on furanone-coated and uncoated wells as above, but omitting the discs. The total microbial mass was determined by OD measurements (600 nm) after vigorous shaking.
The bioluminescence, biofilm and antimicrobial assays were all performed in triplicate in three independent experiments.
Scanning electron microscopy (SEM)
SEM was used to visually confirm the effect of furanone on S. epidermidis biofilm formation. Biofilms were formed as described above on furanone-coated and uncoated polystyrene discs. The discs were removed after 18 h of incubation, rinsed with distilled water and fixed with 2.5% glutaraldehyde in 0.1 M Sørensen phosphate buffer. Samples were successively dried with 30%, 50%, 70% and 90% absolute ethanol for 10 min, sputtered with palladium/gold and then examined by SEM (Model XL 30 ESEM; Philips, Eindoven, The Netherlands).
Irritability testing
The irritability of the furanones was tested by the HET-CAM procedure and was performed as described previously, 29, 30 with slight modifications. Fertilized eggs were purchased (Samvirkekylling, Våler, Norway) and placed in an automatically rotating incubator in a humidified atmosphere at 378C for 9 or 10 days. Removing the shell above the air cell and inner egg membrane using a dental drill, saw blade and forceps gave access to the chorioallantoic membrane (CAM). A volume of 300 mL of furanone F202 or F206 was applied directly on the CAM according to the procedure protocol. 29, 30 An irritative effect of the CAM was examined using a photomacroscope (Wild M400, Wild, Heerbrugg, Switzerland) and recorded as haemorrhage, coagulation or vascular lysis within a period of 5 min. 29, 30 Each furanone concentration and the controls were tested on three eggs the first day and three eggs the second day in two independent experiments. Time was recorded in seconds for the first observation of haemorrhage (time H), lysis (time L) or coagulation (time C). An irritative score was calculated for each egg using the formula:
Test solutions scoring 0-0.9 were classified as non-irritative, 1 -4.9 as slightly irritative, 5-8.9 as moderately irritative and 9-21 as strongly irritative. 29, 30 Saline (0.9%) was used as a negative control, and 0.1 M NaOH as a positive control. Photomicrographs were taken prior to application, and at 30, 150 and 300 s.
The test started with adding 6 mM furanone and continued with doubling the concentration until irritability signs were detected.
Mouse experimental model
F202 and F206 were then assessed for toxicity in CD1 mice. Distilled water with 0.01% EtOH was used as a negative control. The mice, seven in each treatment group, were tube-fed once daily with 100 mL of suspension of either of the furanones or the control. The daily doses were 15 and 22 mg of F202 and F206, respectively. The doses were calculated according to the estimated mean water consumption of 15 mL daily and a furanone concentration of 6 mM, a concentration known to interfere with bacterial communication. 21 Three mice in each group were exposed to the furanones or control for 3 days, and four mice in each group were exposed for 21 days before sacrifice. Significantly reduced body weight or impaired mobility were used as exclusion criteria.
The animal house had a 12 h light/12 h dark cycle and was thermoregulated at 218C with a relative humidity of 60%. Food and water were supplied ad libitum. The animal protocols used were submitted to, and approved by, the local Ethics Committee for experimental animals. The animals were kept according to the regulations of the Norwegian Gene Technology Act of 1994 and were sacrificed by cervical dislocation after 3 or 21 days. The mice were weighed and investigated clinically before sacrifice. After sacrifice, livers, brains and kidneys were weighed, cut into 0.5 cm 2 pieces and immediately immersed in 5 mL of RNAlater (Ambion Inc., TX, USA).
To provide impartiality during the experimental phase and data analysis, the performers were blinded regarding treatment, labelling and data analyses.
RNA isolation for membrane arrays and microarrays
Total RNA was extracted from 30 mg liver samples using a Qiagen RNAeasy Mini Kit TM (Qiagen GmbH, Hilden, Germany). RNA fractions exhibiting a ratio of OD 260 /OD 280 of at least 2.0 were considered suitable for use in oligo membrane assays and oligo microarray experiments. The quality of isolated RNA was assessed by using the RNA 6000 Nano Kit (Agilent Technologies Inc., Santa Clara, CA, USA). Gene expression was analysed using both membrane arrays and microarrays.
Genotoxic effect of furanones
EMM-401 oligo GEArray membrane arrays (SuperArray, MD, USA) were used to study genotoxic effects. Each membrane array was hybridized with amplified RNA (aRNA) obtained from 1 mg of total RNA. Total RNA from mice exposed for 3 and 21 days was converted into biotin-labelled cDNA using the TrueLabeling-AMP TM 2.0 Kit (SuperArray) according to the kit specifications. Biological replicates of total RNA from mice treated with furanone F202, furanone F206 or the control were used for each membrane array. Signal detection was carried out by incubating the arrays with AP-streptavidin and CDP-Star w . The membrane arrays were scanned in a ProXPRESS proteomic imaging system (Perkin Elmer Life and Analytical Science, Inc., MA, USA) and chemiluminescence was detected at 530 nm. Pixel intensity was quantified with TotalLab v2.01 (Nonlinear Dynamics Ltd, Newcastle Upon Tyne, UK).
Effect of furanone on global gene expression
Murine oligo(30 k)-microarray slides, printed using the Operon murine v. 3 oligo set (Qiagen GmbH), were purchased from the NTNU Microarray Core Facility, Trondheim, Norway.
cDNA was synthesized from 1 mg total RNA samples, isolated from livers of mice treated with furanone F202, furanone F206 or the control. cDNA synthesis, Cy5/Cy3 labelling and hybridization were carried out using the Genisphere 3DNA Array 900 TM detection kit (Genisphere, PA, USA) as described by the manufacturer. The microarrays were scanned in a Packard Bioscience Scanarray Lite (Perkin Elmer Life and Analytical Science, Inc.) microarray scanner. The fluorescence signals (Cy5/Cy3) were quantified with the Scan Array Express v. 22 TM program (Perkin Elmer Life and Analytical Science, Inc.).
Biological replicates for each treatment compared with control were used in three separate microarrays: (i) furanone F206 (Cy3) against control (Cy5); (ii) furanone F206 (Cy3) against furanone F202 (Cy5); and (iii) control (Cy3) against furanone F202 (Cy5).
Statistics
One-way ANOVA followed by the Student -Newman-Keuls method were used for multiple comparisons on biofilm formation and growth, and for comparisons of bioluminescence induction.
Statistical evaluation (two-tailed t-test) of the Oligo GEArray data was carried out using GraphPad InStat (Graphpad Software Inc., USA). The combined Oligo GEArray data were analysed using Spotfire v.8 TM Functional Genomics software (Spotfire, MA, USA). Statistical analyses of the microarray data were carried out using Spotfire v.8 TM Functional Genomics software and the Limma Guide Spotfire Application Package (Integromics, Madrid, Spain). The median values with background subtracted were filtered. The filtration criteria were as follows: spots with net fluorescence intensity below 300 or above 62 000 were removed. The remaining values were converted into log 2 scale and subjected to Z-score normalization 36 and subsequent median subtract normalization was performed. The false discovery rate of Benjamini and Hochberg 37 was used. For all statistical analyses, the level of statistical significance was set at P , 0.01.
Results
Bioluminescence was induced by S. epidermidis supernatant and decreased by furanones
Supernatant from S. epidermidis induced bioluminescence in V. harveyi BB170, indicating that S. epidermidis communicates via AI-2. The furanones F201, F202, F206 and F302 decreased bioluminescence the most, but there was no significant difference in reduction between the four different structures ( Figure 2 ).
Furanones decreased biofilm formation
Furanone coating with F201, F202, F206 or F302 decreased S. epidermidis biofilm formation by 55%, 68%, 58% and 57%, respectively (Figure 3a) . At the concentrations used, no effect on total microbial growth was observed concentrations 1000 and 1600 mM were established as the MICs of F202 and F206, respectively.
DPD abolished the effect of furanones on biofilm formation DPD at 0.5 nM completely eliminated the biofilm inhibitory effect of the F202 (Figure 3b ) or F206 (Figure 3c ) furanone coatings, indicating that the furanones decrease biofilm formation by interfering with bacterial quorum sensing. DPD concentrations above or below 0.5 nM attenuated the effect of the furanones.
Furanones had no irritative effect at biofilm reducing concentrations
The furanones F202 and F206 were tested for irritability in the HET-CAM assay. None of the tested furanones showed blood coagulation, injury to the blood vessel walls or haemorrhage when added to the CAM until a concentration of 6000 mM was reached. After 240 s, at 6000 mM, a small transient bleeding and initial signs of coagulation, which were later resolved, were observed for F206. For F202, initial signs of coagulation, which were later resolved, were observed after 240 s at 6000 mM. This was concluded after comparing the furanones with the positive control showing coagulation, lysis and bleeding effects within the first 30 s; and the negative control with no coagulation, lysis or bleeding effects. Direct visualization of the damage with the highest concentrations, 6000 mM, made to the CAM were, however, transient and not visible in photographs, since mild coagulation is only visible when observing movements and the minor bleeding was not captured by the photograph. The tested furanones were therefore classified as non-irritative at the concentration used in the biofilm assay.
Genotoxic and global gene expression effects of the furanones
The clinical investigation of the mice and their livers, brains and hearts after sacrifice revealed no differences in weight, form or appearance between the treatments. This gave a first indication that the animals were healthy and that they were not affected by the furanones.
The chemiluminescence measurement of membrane arrays showed no difference in the gene expression in mice treated for 3 or 21 days with furanones F202 or F206 or the control (data not shown).
Analysis of the microarray data showed no significant differences in gene expression of the 30 000 genes included in the microarray in mice treated for 21 days with furanone F202 or F206 compared with the control. The furanones tested seemed to have no significant effect on global gene expression in mice. The microarray data files have been deposited in the ArrayExpress database with the reference number E-MEXP-1249.
Discussion
In the present study, we investigated whether furanones would be potential agents for preventing bacterial biofilm formation on catheters and implants from a biofilm reducing, irritative and genotoxic point of view.
Four furanones resembling the natural brominated furanones 38 found in the algae D. pulchra and seven previously synthesized furanones were compared for their ability to interfere with AI-2 communication. Bioluminescence assays have previously shown that both natural and synthetic furanones interfere with AI-1 10, 39 and AI-2 21,39,40 communication. The fact that S. epidermidis induced bioluminescence in a V. harveyi mutant only sensing AI-2 indicated that S. epidermidis communicates through AI-2. Since the synthetic furanones decreased bioluminescence, this may indicate that furanones have the potential to interfere with bacterial communication. Furanones F201, F202, F206 and F302 were the most effective, prompting us to assess their potential antibiofilm effect.
The furanone F202 decreased biofilm formation more effectively than F201, F206 and F302, whereas in the bioluminescence assay, no differences were observed between the four furanones. Bioluminescence results should be interpreted with caution, since the sensitivity of the method is considered to be low. 41 In this study, the assay was used as a primary screening of the compounds. F202 and F206 were structurally interesting since F202 contained one bromo substituent and F206 contained two bromo substituents. F202 and F206 were therefore included in the further studies.
Notably, the bacterial growth of S. epidermidis was unaffected by F202 and F206 at concentrations that decreased biofilm formation. This excludes an antibacterial effect, confirming previous results. 21 MICs of both furanones used were in the range of 1000 -1600 mM. The concentration used in the biofilm assay and the maximum concentration that the bacteria could be exposed to are well below the established MIC values. This supports a non-antimicrobial biofilm inhibitory effect. The furanones will probably exert limited selective pressure on S. epidermidis and therefore may avoid antimicrobial resistance development.
Furthermore, the effects of the two furanones could be eliminated by the AI-2 precursor, indicating that the furanones affect biofilm formation through interference with bacterial communication. The narrow range of DPD inducing a quorum-sensing response has been observed in several studies. 34, 42 A recent study 43 showed that externally added AI-2 almost completely restored the gene expression patterns of the wild-type in the luxS mutant of S. epidermidis and that virulence-and metabolic-associated factors were regulated by AI-2. Most interestingly, AI-2 was found to regulate expression of phenolsoluble modulins, which seem to have a function in biofilm development. Evidence that furanones interfere with AI-2 communication has previously been found in Escherichia coli 13 and in S. anginosus, S. intermedius and S. mutans. 21 However, findings that a luxS mutant of S. epidermidis formed more biofilm than the wild-type 44 oppose a furanone effect through inhibition of AI-2 communication. This is in contrast with our results showing that DPD restores the ability of S. epidermidis to form biofilm when decreased by furanone. Differences in results may be related to factors such as biofilm growth conditions, e.g. growth medium, culture well materials and quantification methods. Thus, further studies on the furanone mechanism of action are warranted.
In V. harveyi, furanone was found to structurally alter LuxR in such a way that LuxR was unable to bind to promoter sequences of quorum-sensing-regulated genes. 39 When searching the S. epidermidis genome, we found two open reading frames encoding putative response regulators belonging to the luxR family (http://img.jgi.doe.gov/cgi-bin/pub/main.cgi). However, the functions of these reading frames and their possible involvement in AI-2 communication are presently unknown.
Future clinical use of furanones depends on minimal adverse effects. Therefore, we also investigated the irritative effect of furanones F202 and F206. We used the HET-CAM method to predict any irritative effect on the sensitive tissue surrounding a medical device. The acute effects on the blood vessels of the CAM are comparable to the irritative effect by the same chemical tested in the Draize eye irritation test, an accepted and commonly used method for irritability testing. 30 The irritative potential was assessed from the score taking all reactions of the CAM into consideration. 29 We found that there were no irritative effects at the concentrations used in the biofilm assay.
From the presence of a 5-bromomethylene substituent, which theoretically could be transformed into an a-bromo keto group under hydrolytic conditions, one could suspect a toxic effect of the furanones. The molecules are, however, stable molecules, compared with DPD, which is highly unstable, as NMR analysis of more than 1-year-old furanones stored in ethanol showed no structural alterations (data not shown). In the membrane arrays, no significant genotoxic effects by furanones F202 and F206 in mice after 3 or 21 days of exposure at concentrations inhibiting biofilm formation were seen. In the microarray, none of the genes was significantly altered in expression when comparing control without furanone, furanone F202 and furanone F206. There is, however, still a need for long-term toxicity studies as well as studies on toxic effects on offspring.
In conclusion, this study shows that synthetic furanones may inhibit biofilm formation by S. epidermidis. The two furanones evaluated for effects on bacterial communication had no irritative or genotoxic effects. The effects of furanones on biofilm formation were most probably related to interference with AI-2 communication, since the addition of DPD eliminated the decreasing effect of the furanones at 0.5 nM. This would offer possibilities for the use of furanones to prevent biofilm infections, for instance as coatings on implants.
